title: mRNA expression of CDH3, IGF2BP3, and BIRC5 in biliary brush cytology specimens is a useful adjunctive tool of cytology for the diagnosis of malignant biliary stricture.
abstract: Although advances have been made in diagnostic tools, the distinction between malignant and benign biliary strictures still remains challenging. Intraductal brush cytology is a convenient and safe method that is used for the diagnosis of biliary stricture, but, low sensitivity limits its usefulness. This study aimed to demonstrate the usefulness of mRNA expression levels of target genes in brush cytology specimens combined with cytology for the diagnosis of malignant biliary stricture. Immunohistochemistry for cadherin 3 (CDH3), p53, insulin-like growth factor II mRNA-binding protein 3 (IGF2BP3), homeobox B7 (HOXB7), and baculoviral inhibitor of apoptosis repeat containing 5 (BIRC5) was performed in 4 benign and 4 malignant bile duct tissues. Through endoscopic or interventional radiologic procedures, brush cytology specimens were prospectively obtained in 21 and 35 paitents with biliary strictures. In the brush cytology specimens, the mRNA expressions levels of 5 genes were determined by real-time polymerase chain reaction. Immunohistochemistry for CDH3, p53, IGF2BP3, HOXB7, and BIRC5 all showed positive staining in malignant tissues in contrast to benign tissues, which were negative. In the brush cytology specimens, the mRNA expression levels of CDH3, IGF2BP3, HOXB7, and BIRC5 were significantly higher in cases of malignant biliary stricture compared with cases of benign stricture (P = 0.006, P < 0.001, P < 0.001, and P = 0.001). The receiver-operating characteristic curves of these 4 mRNAs demonstrated that mRNA expression levels are useful for the prediction of malignant biliary stricture (P = 0.006, P < 0.001, P < 0.001, and P = 0.002). The sensitivity and specificity, respectively, for malignant biliary stricture were 57.1% and 100% for cytology, 57.1% and 64.3% for CDH3, 76.2% and 100% for IGF2BP3, 71.4% and 57.1% for HOXB7, and 76.2% and 64.3% for BIRC5. When cytology was combined with the mRNA levels of CDH3, IGF2BP3, or BIRC5, the sensitivity for malignant biliary stricture improved to 90.5%. The measurement of the mRNA expression levels of CDH3, IGF2BP3, and BIRC5 by real-time polymerase chain reaction combined with cytology was useful for the differentiation of malignant and benign biliary strictures in brush cytology specimens.
authors.affiliation: Department of Internal Medicine Institute of Clinical Medicine Research Department of Hospital Pathology Department of Radiology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
authors.forename: Tae Ho
authors.initials: TH
authors.lastname: Kim
authors.forename: Jae Hyuck
authors.initials: JH
authors.lastname: Chang
authors.forename: Hee Jin
authors.initials: HJ
authors.lastname: Lee
authors.forename: Jean A
authors.initials: JA
authors.lastname: Kim
authors.forename: Yeon Soo
authors.initials: YS
authors.lastname: Lim
authors.forename: Chang Whan
authors.initials: CW
authors.lastname: Kim
authors.forename: Sok Won
authors.initials: SW
authors.lastname: Han
mesh_terms: D000368:Aged; D001650:Bile Duct Neoplasms / Q000150:complications / Q000235:genetics* / Q000473:pathology*; D015820:Cadherins / Q000235:genetics*; D018281:Cholangiocarcinoma / Q000150:complications / Q000235:genetics* / Q000473:pathology*; D002779:Cholestasis / Q000209:etiology / Q000473:pathology*; D003581:Cytodiagnosis / Q000379:methods; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D051034:Inhibitor of Apoptosis Proteins / Q000235:genetics*; D008297:Male; D011446:Prospective Studies; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis*; D016601:RNA-Binding Proteins / Q000235:genetics*; D000077022:Survivin
chemical_list: C107489:BIRC5 protein, human; C512197:CDH3 protein, human; D015820:Cadherins; C498780:IGF2BP3 protein, human; D051034:Inhibitor of Apoptosis Proteins; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; D000077022:Survivin